Tetrahydropyrazolopyrimidine compounds
Abstract:
Embodiments of the disclosure relate to tetrahydropyrazolopyrimidine compounds that act as antagonists or inhibitors for Toll-like receptors 7 and/or 8, and their use in pharmaceutical compositions effective for treatment of systemic lupus erythematosus (SLE) and lupus nephritis.
Public/Granted literature
Information query
Patent Agency Ranking
0/0